Promising DMG Treatment for MIH Presented at AAPD 2026

 

Leading MIH researcher presents treatment being used successfully in Europe

A standing-room-only audience at the recent annual conference of the American Academy of Pediatric Dentistry in Las Vegas was treated to an illuminating and encouraging presentation about the documented ability of DMG Icon® resin infiltration to treat Molar-Incisor Hypomineralization, or MIH. The presentation was given by Dr. Katrin Bekes, Professor and Head of Pediatric Dentistry at the Medical University of Vienna. Dr. Bekes is a world-renowned expert on MIH and a long-time supporter of the efforts of DMG researchers to find an effective and efficient treatment for a disease that afflicts one-in-seven children worldwide.

Icon is already indicated for use as an MIH treatment in the European Union and other countries.  DMG is currently working to secure the Federal Drug Administration’s clearance for Icon as an indication for MIH, as well as for trauma and enamel porosities, in the United States.  The AAPD 2026 conference afforded DMG an opportunity to increase awareness of several new Icon protocols, including transillumination, bleaching pre-treatment with 3D-printed bleaching trays for discolored opacities, micro- or air-abrasion for tougher and deeper lesions, and extended infiltration time. Dr. Carla Cohn, Dr. Bilyana Daskalova, Dr. Alyssa Delgado also gave lectures about their use of Icon for various approved indications. It also allowed the company to make pediatric dentists aware that Icon may soon be indicated for treatment of MIH.

However, as Dr. Bekes pointed out, treating MIH requires a totally different approach from treating carious lesions and white spot lesions. The condition is sometimes referred to as “chalky teeth” due to yellowish/brownish discoloration, large opacities, unstable molar structure, and enamel defects such as decavitation. Little is currently known about the multivariate causes of MIH, in part because the disease starts to build in the teeth years before it is diagnosed. But what is known that the condition can cause hypersensitivity and even chronic pain to children.  And, according to Dr. Bekes, an even more damaging effect can be the psychological trauma and embarrassment caused by teasing peers that lead some children with MIH to avoid smiling or speaking.

DMG researchers in Germany recently announced the first evidence-based, validated treatment concept for MIH lesions worldwide. The treatment protocol, developed by the DMG clinical research team in collaboration with Dr. Bekes and other leading MIH experts, offers a minimally invasive approach that removes discoloration and stabilizes the teeth. As Dr. Bekes explained, the first step in the protocol is bleaching to remove the brown discoloration composed of proteins. While bleaching agents for whitening purposes are not widely approved for use withchildren, DMG’s Flairesse Bleaching Gel is approved for use in the pediatric treatment of MIH in many countries due to its status as a medical device approved for the treatment of enamel opacities. (It will be launched as a 510K-exempt Class I medical device in the U.S. in the second half of 2026.) The bleaching takes place at home using DMG bleaching trays specially designed to prevent the bleaching agent from coming into contact with the gingiva. Once this step is completed, the teeth are conditioned and ready for the application of the Icon Caries Infiltrant in the dental practice. The protocol’s outcomes have been very well received by practitioners, patients and parents alike.

"With one in seven children globally impacted by MIH, it’s no wonder MIH was one of the hottest topics at AAPD 2026,” said John Scott, Clinical Affairs Director at DMG America. “In fact, because Dr. Bekes’s talk drew so many attendees, the AAPD has asked us to submit a proposal for a follow-up presentation on treating MIH on the main stage of AAPD 2027.”  For more about bleaching and MIH, visit https://onlinelibrary.wiley.com/doi/10.1111/jerd.70056.

For more about transillumination and MIH, visit

https://onlinelibrary.wiley.com/doi/10.1111/ipd.70064.

About DMG

DMG manufactures and distributes a full range of market-leading dental materials and equipment that are internationally recognized for their quality and innovation. Known for its breakthrough dental technology – including flagship products like Luxatemp® and LuxaCore® Z Dual, the revolutionary Icon® caries infiltrant, LuxaCrown® long-term crown and bridge material, and new additions such as Ecosite restorative composites, and DentaMile® 3D printing solution, complete with software, hardware and resins – DMG is committed to helping provide holistic solutions and streamlined workflows for dental and lab professionals to meet their needs through innovation, collaboration, and dedication. 

For more information about DMG products, or to find a sales representative, please visit online at www.dmg-america.com, or call 800-662-6383.